Related Experiment Videos
[Thyroid scintigraphy in patients with thyroid tumors using 99mTc-hexakis 2-methoxy isobutyl isonitrile]
1Department of Radiology, National Defense Medical College, Tokorozawa, Saitama.
Kaku Igaku. the Japanese Journal of Nuclear Medicine
|November 1, 1994
Summary
Technetium-99m hexakis 2-methoxy isobutyl isonitrile (99mTc-MIBI) scintigraphy shows increased uptake in solid thyroid tumors and metastases. While useful for detection, it cannot distinguish between benign and malignant thyroid lesions.
Area of Science:
- Nuclear Medicine
- Oncology
- Radiology
Background:
- Thyroid tumors require accurate diagnostic imaging.
- Technetium-99m hexakis 2-methoxy isobutyl isonitrile (99mTc-MIBI) is a radiotracer used in nuclear medicine.
- Evaluating the utility of 99mTc-MIBI for thyroid tumor imaging is important.
Purpose of the Study:
- To assess the effectiveness of 99mTc-MIBI scintigraphy in detecting thyroid tumors and their metastases.
- To compare the image quality of 99mTc-MIBI scintigraphy with other radionuclides like 201Tl.
Main Methods:
- Early and delayed scintigraphy using 99mTc-MIBI was performed on 18 patients with various thyroid tumors (carcinomas, adenomas, lymphoma).
- Scintigraphic findings were compared with those obtained using other radionuclides.
- Tumor uptake and washout patterns were analyzed.
Main Results:
- Increased 99mTc-MIBI uptake was observed in all 11 malignant tumors and 14 solid thyroid tumors.
- Metastatic cervical lymph nodes showed 99mTc-MIBI concentration.
- Solid thyroid adenomas demonstrated intense tracer uptake, while cystic adenomas showed defects.
- 99mTc-MIBI scintigraphy quality was comparable or superior to 201Tl scintigraphy.
Conclusions:
- 99mTc-MIBI scintigraphy is valuable for detecting solid thyroid tumors and metastases.
- The technique shows increased tracer accumulation in malignant and solid benign thyroid tumors.
- 99mTc-MIBI scintigraphy cannot reliably differentiate between benign and malignant thyroid tumors.